Home › Adaptive Biotechnologies Receives $2.53 million Phase II Sbir to...
 

Keywords :   


Adaptive Biotechnologies Receives $2.53 million Phase II Sbir to...

2013-09-14 06:04:40| Logistics - Topix.net

Adaptive Biotechnologies announced today that it received a $2.53 million Phase II Small Business Innovation Research award from the National Heart, Lung, and Blood Institute, a division of the NIH, to commercialize a test to measure the ability of a cancer patient's adaptive immune system to fight infection after a cord blood transplant.

Tags: to million phase receives

Category:Transportation and Logistics

Latest from this category

All news
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 20
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Public Advisory Number 20
03.07Hurricane Beryl Forecast Advisory Number 20
03.07Hurricane Beryl Graphics
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Public Advisory Number 19A
Transportation and Logistics »
03.07Print Quest invests in two more Miraclon Shine LED lamp kits
03.07ETI celebrates grand opening of new headquarters in Spain
03.07Mondi unveils FlexiBag Reinforced
03.07Nilpeter announces new partnership in the Philippines
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 20
03.07Hurricane Beryl Public Advisory Number 20
03.07Summary for Hurricane Beryl (AT2/AL022024)
More »